jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Hypertension Package

Blood

83 parameters

image

Report in 24Hrs

image

At Home

fastingrequire

Fasting Required

Details

Comprehensive hypertension profile check - glucose, albumin, creatinine, kidney, liver, cortisol, lipid, urine, vitamins, thyroid, blood

₹2,799₹4,499

38% OFF

Parameters

  • List of Tests
    • Sugar (Glucose) Fasting
    • Microalbumin, Microalbumin Creatinine Ratio (Spot), Spot Urinary Creatinine
    • Cortisol
    • Liver Function Test
      • Albumin
      • Alkaline Phosphatase
      • Bilirubin - Direct
      • Bilirubin - Indirect
      • Bilirubin - Total
      • AST/SGOT
      • ALT/SGPT
      • Total Protein
      • A/G Ratio
      • Gamma GT
      • Globulin
    • Kidney Profile
      • BUN
      • Calcium
      • Creatinine
      • Uric Acid
      • eGFR
      • BUN/Creatinine
      • Urea
    • Lipid Profile
      • Cholestrol/HDL
      • LDL/HDL
      • Non HDL
      • VLDL
      • Total Cholestrol
      • Triglycerides
      • HDL
      • LDL
    • Thyroid Profile
      • Total T3
      • Total T4
      • TSH
    • Hba1c
    • eAG
    • CBC - Complete Hemogram
    • Urine Complete
    • Vitamin - B12
    • 25 OH D

Hypertension Package - Comprehensive Diagnostic Guide

  • Why is it done?
    • Comprehensive evaluation of hypertension etiology and associated comorbidities to identify underlying causes and risk factors
    • Assessment of end-organ damage and hypertensive complications affecting kidneys, heart, and metabolic function
    • Screening for secondary causes of hypertension including endocrine disorders (cortisol excess, thyroid disease)
    • Evaluation of metabolic risk factors including glucose control, lipid disorders, and renal function
    • Detection of microalbuminuria as an indicator of early diabetic and hypertensive nephropathy
    • Initial screening for newly diagnosed hypertension to establish baseline organ function and stratify cardiovascular risk
    • Monitoring response to antihypertensive therapy and detection of medication-related complications
    • Assessment of nutritional status and micronutrient deficiencies (Vitamin B12, Vitamin D) that may affect hypertension management
    • Complete hematologic evaluation to rule out anemia and detect blood disorders affecting oxygen delivery
    • Urinary analysis to identify proteinuria, hematuria, and urinary tract abnormalities associated with hypertensive disease
  • Normal Range
    • Sugar (Glucose) Fasting: 70-100 mg/dL (3.9-5.6 mmol/L); Normal <100 mg/dL fasting
    • Microalbumin (Spot Urine): <30 mg/L or <30 mcg/mg creatinine; Normal: Negative or <20 mg/L
    • Microalbumin Creatinine Ratio: <30 mcg/mg creatinine; Normal: <30 mcg/mg
    • Spot Urinary Creatinine: 500-2000 mg/24 hours (equivalent); Normal: 40-300 mg/dL in random spot urine
    • Cortisol (Morning): 5-25 mcg/dL (138-690 nmol/L); Normal: 10-20 mcg/dL at 8 AM
    • Liver Function Tests - Albumin: 3.5-5.0 g/dL (35-50 g/L)
    • Alkaline Phosphatase: 30-120 U/L (0.5-2.0 mckat/L)
    • Total Bilirubin: 0.1-1.2 mg/dL (1.7-20.5 mcmol/L)
    • Direct Bilirubin: 0.0-0.3 mg/dL (0-5.1 mcmol/L)
    • Indirect Bilirubin: 0.1-0.9 mg/dL (1.7-15.4 mcmol/L)
    • AST (SGOT): 10-40 U/L (0.17-0.67 mckat/L)
    • ALT (SGPT): 7-56 U/L (0.12-0.94 mckat/L)
    • Total Protein: 6.0-8.3 g/dL (60-83 g/L)
    • A/G Ratio (Albumin/Globulin): 1.0-2.5
    • Gamma GT (GGT): 0-55 U/L (0-0.92 mckat/L)
    • Globulin: 2.0-3.5 g/dL (20-35 g/L)
    • Kidney Profile - BUN (Blood Urea Nitrogen): 7-20 mg/dL (2.5-7.1 mmol/L)
    • Creatinine: 0.7-1.3 mg/dL (62-115 mcmol/L) for males; 0.6-1.1 mg/dL (53-97 mcmol/L) for females
    • Calcium: 8.5-10.2 mg/dL (2.13-2.55 mmol/L)
    • Uric Acid: 3.5-7.2 mg/dL (208-428 mcmol/L) for males; 2.6-6.0 mg/dL (155-357 mcmol/L) for females
    • eGFR (Estimated Glomerular Filtration Rate): >60 mL/min/1.73m² (Normal kidney function); Stage 1: ≥90, Stage 2: 60-89
    • BUN/Creatinine Ratio: 10:1 to 20:1; Normal ratio indicates appropriate kidney function
    • Urea: 2.5-7.1 mmol/L (7-20 mg/dL)
    • Lipid Profile - Total Cholesterol: <200 mg/dL (<5.18 mmol/L); Desirable <200
    • HDL (High-Density Lipoprotein): >40 mg/dL (>1.04 mmol/L) for males; >50 mg/dL (>1.30 mmol/L) for females; Optimal >60 mg/dL
    • LDL (Low-Density Lipoprotein): <100 mg/dL (<2.59 mmol/L); Optimal <100 (high-risk <70)
    • VLDL (Very Low-Density Lipoprotein): <30 mg/dL (<0.78 mmol/L); Normal <30
    • Triglycerides: <150 mg/dL (<1.69 mmol/L); Normal <150
    • Cholesterol/HDL Ratio: <5.0 (lower ratio indicates better cardiovascular health)
    • LDL/HDL Ratio: <3.0 (optimal cardiovascular risk profile)
    • Non-HDL Cholesterol: <130 mg/dL (<3.37 mmol/L); Calculated as Total Cholesterol - HDL
    • Thyroid Profile - TSH: 0.4-4.0 mIU/L (or 0.5-5.0 mIU/L depending on lab); Normal range indicates normal thyroid function
    • Total T3 (Triiodothyronine): 80-200 ng/dL (1.23-3.07 nmol/L); Normal range
    • Total T4 (Thyroxine): 4.5-12 mcg/dL (58-154 nmol/L); Normal range
    • HbA1c (Glycated Hemoglobin): <5.7% (<39 mmol/mol); Normal <5.7%, Prediabetes 5.7-6.4%, Diabetes ≥6.5%
    • eAG (Estimated Average Glucose): <117 mg/dL (<6.5 mmol/L) corresponding to HbA1c <5.7%; Derived from HbA1c value
    • CBC (Complete Blood Count) - Hemoglobin (Hb): 13.5-17.5 g/dL for males; 12.0-15.5 g/dL for females (135-175 g/L and 120-155 g/L respectively)
    • Hematocrit (Hct): 41-53% for males; 36-46% for females
    • Red Blood Cell (RBC) Count: 4.5-5.9 × 10⁶/mcL for males; 4.1-5.1 × 10⁶/mcL for females
    • Mean Corpuscular Volume (MCV): 80-100 fL (femtoliters)
    • Mean Corpuscular Hemoglobin (MCH): 27-33 pg (picograms)
    • Mean Corpuscular Hemoglobin Concentration (MCHC): 32-36 g/dL
    • White Blood Cell (WBC) Count: 4.5-11.0 × 10³/mcL (4.5-11.0 K/mcL)
    • Neutrophils: 50-70% or 2.0-7.0 × 10³/mcL
    • Lymphocytes: 20-40% or 1.0-4.8 × 10³/mcL
    • Monocytes: 2-11% or 0.2-0.9 × 10³/mcL
    • Eosinophils: 1-4% or 0.05-0.5 × 10³/mcL
    • Basophils: 0-1% or 0.0-0.1 × 10³/mcL
    • Platelet Count: 150-400 × 10³/mcL (150-400 K/mcL)
    • Mean Platelet Volume (MPV): 7.4-10.4 fL
    • RBC Distribution Width (RDW): 11.5-14.5% or 9.0-16.0 depending on lab
    • Urine Complete - Appearance: Clear to pale yellow; Normal = clear
    • Urine pH: 4.5-8.0; Normal slightly acidic to neutral
    • Urine Specific Gravity: 1.005-1.030; Normal indicates adequate hydration
    • Urine Protein: Negative or <150 mg/24 hours; Trace amounts normal
    • Urine Glucose: Negative or <100 mg/24 hours; Normal is absent
    • Urine Ketones: Negative; Normal is absent
    • Urine Bilirubin: Negative; Normal is absent
    • Urine Urobilinogen: <1 mg/dL; Normal trace to 1 mg/dL
    • Urine Nitrites: Negative; Normal is negative (absence indicates no bacterial infection)
    • Urine Leukocyte Esterase: Negative; Normal is negative
    • Urine RBC: 0-3/hpf (high power field); Normal is negative or minimal
    • Urine WBC: 0-5/hpf; Normal is negative or minimal
    • Urine Crystals: Negative or rare; Normal is absent or trace
    • Urine Casts: Negative or 0-2/lpf (low power field); Normal is negative
    • Urine Bacteria: Negative or rare; Normal is negative
    • Vitamin B12: 200-900 pg/mL (or 150-650 pmol/L); Normal range indicates adequate B12 stores
    • 25-OH Vitamin D (Calcifediol): 30-100 ng/mL (75-250 nmol/L); Sufficient ≥30 ng/mL, Deficiency <20 ng/mL
  • Interpretation
    • Fasting Glucose Interpretation: 100-125 mg/dL indicates impaired fasting glucose (prediabetes); ≥126 mg/dL suggests diabetes; <100 mg/dL is normal; Hypertensive patients with elevated glucose have increased cardiovascular risk
    • Microalbuminuria Interpretation: 30-300 mcg/mg creatinine (microalbuminuria range) indicates early kidney damage; >300 mcg/mg suggests overt proteinuria/albuminuria; Presence indicates hypertensive nephropathy and increased cardiovascular and renal risk; Requires intervention to slow progression
    • Cortisol Interpretation: Elevated cortisol (>25 mcg/dL) suggests secondary hypertension from Cushing syndrome; Normal values help exclude endocrine causes of hypertension; Midnight cortisol >7.5 mcg/dL indicates possible hypercortisolism; Multiple elevated values warrant further investigation
    • Liver Function Tests Interpretation: Elevated AST/ALT (>40 U/L) indicates hepatocyte injury, may be related to hypertensive complications, fatty liver, or medication effects; Elevated bilirubin suggests liver dysfunction or hemolysis; Low albumin (<3.5 g/dL) indicates poor synthetic function or malnutrition; Elevated GGT suggests alcoholic liver disease or bile duct obstruction; Abnormalities may impact antihypertensive drug metabolism
    • Kidney Profile Interpretation: Creatinine >1.3 mg/dL indicates reduced kidney function; BUN >20 mg/dL suggests renal impairment or dehydration; eGFR <60 mL/min indicates chronic kidney disease (CKD); BUN/Creatinine ratio >20:1 suggests prerenal azotemia; eGFR 30-59 is CKD Stage 3, 15-29 is Stage 4, <15 is Stage 5; Elevated uric acid (>7 mg/dL) increases gout and cardiovascular risk; Abnormal calcium (hypercalcemia or hypocalcemia) needs investigation
    • Lipid Profile Interpretation: Total cholesterol ≥240 mg/dL, LDL ≥130 mg/dL, triglycerides ≥200 mg/dL indicate dyslipidemia requiring treatment; HDL <40 mg/dL (males) or <50 mg/dL (females) is unfavorable; Elevated triglycerides with metabolic syndrome increase hypertension severity; Low HDL and high triglycerides indicate metabolic risk; Ratio abnormalities correlate with atherosclerotic risk
    • Thyroid Profile Interpretation: TSH >4.0 mIU/L suggests hypothyroidism (can cause or worsen hypertension); TSH <0.4 mIU/L suggests hyperthyroidism (can cause secondary hypertension); Low Free T4 with high TSH confirms primary hypothyroidism; High T4 and T3 with suppressed TSH indicates hyperthyroidism; Abnormal thyroid function affects cardiovascular regulation and medication efficacy
    • HbA1c/eAG Interpretation: HbA1c 5.7-6.4% indicates prediabetes; HbA1c ≥6.5% confirms diabetes; HbA1c >8% indicates suboptimal glycemic control; Values reflect average glucose over 2-3 months; eAG provides estimated average daily glucose equivalent; Diabetic hypertensive patients require tighter glycemic control (<7% typically); Poor glucose control increases cardiovascular event risk
    • CBC Interpretation: Hemoglobin <12 g/dL (females) or <13.5 g/dL (males) indicates anemia, affecting oxygen delivery and potentially worsening hypertension; Elevated WBC (>11 K/mcL) suggests infection or inflammation; Low platelets (<150 K/mcL) indicates thrombocytopenia; Elevated MCV (>100 fL) suggests macrocytic anemia; Low MCV (<80 fL) suggests microcytic anemia; Left shift in differential (increased immature neutrophils) indicates acute infection; Abnormal values may indicate secondary conditions or medication effects
    • Urine Complete Interpretation: Proteinuria (>150 mg/24 hours) indicates glomerular damage or hypertensive nephropathy; Hematuria (>3 RBC/hpf) suggests kidney disease, stones, or infection; Pyuria (>5 WBC/hpf) indicates urinary tract infection; Casts (>2/lpf) suggest intrinsic kidney disease; Glucose in urine indicates hyperglycemia or glycosuria; Bacteria with positive nitrites and leukocyte esterase indicates UTI; pH abnormalities may predispose to stone formation; Specific gravity indicates hydration status
    • Vitamin B12 Interpretation: <200 pg/mL indicates B12 deficiency; 200-400 pg/mL is low-normal (may have symptoms); Values correlate with neurologic and hematologic complications; Deficiency affects methylation and neurologic function; Some antihypertensive medications may impair B12 absorption
    • Vitamin D Interpretation: 20-29 ng/mL indicates insufficiency; <20 ng/mL indicates deficiency; Vitamin D deficiency associated with worse hypertension control and increased cardiovascular risk; Optimal levels (30-100 ng/mL) support bone health, immune function, and cardiovascular regulation; Supplementation may improve blood pressure in deficient patients
  • Associated Organs
    • Glucose/Pancreas: Evaluates pancreatic beta-cell function; Elevated glucose increases diabetes risk; Diabetes and hypertension together cause accelerated atherosclerosis; Impaired glucose control requires intensive hypertension management
    • Microalbumin/Kidneys: Detects early hypertensive and diabetic nephropathy; Indicates glomerular filtration barrier dysfunction; Microalbuminuria is marker of systemic endothelial damage; Progression to overt proteinuria leads to kidney failure; Early detection allows intervention to prevent CKD progression
    • Cortisol/Adrenal Glands: Evaluates adrenal cortex function; Screens for Cushing syndrome as cause of secondary hypertension; Elevated cortisol causes sodium retention, hypokalemia, and vasoconstriction; Cushing syndrome associated with insulin resistance and dyslipidemia
    • Liver Function/Liver: Assesses hepatic synthetic capacity and detoxification; Abnormal LFTs may indicate cirrhosis, fatty liver disease, or medication toxicity; Hypertensive patients on multiple medications need liver monitoring; Hypertension associated with portal hypertension and hepatic fibrosis; Antihypertensive drugs metabolized by liver; Portal hypertension complicates hypertension management
    • Kidney Profile/Kidneys: Evaluates glomerular filtration and tubular function; Measures creatinine clearance via eGFR; Determines kidney disease stage and progression; Elevated BUN/Creatinine suggests prerenal disease; Hyperkalemia from kidney disease complicates ACE inhibitor use; Hypertension causes progressive kidney damage; CKD increases cardiovascular mortality risk
    • Lipid Profile/Heart and Blood Vessels: Assesses cardiovascular risk profile; Dyslipidemia combined with hypertension dramatically increases atherosclerotic disease; LDL contributes to arterial plaque formation; Low HDL removes plaque; Elevated triglycerides associated with metabolic syndrome; Lipid abnormalities require aggressive management in hypertensive patients
    • Thyroid Profile/Thyroid: Evaluates thyroid hormone production and metabolism; Hypothyroidism causes hypertension, dyslipidemia, and reduced cardiac output; Hyperthyroidism causes tachycardia and systolic hypertension; Thyroid dysfunction affects antihypertensive drug efficacy; Thyroid autoimmunity may coexist with hypertension
    • HbA1c/Pancreas and Circulation: Reflects long-term glucose control affecting pancreatic function; Hyperglycemia causes vascular damage, hypertrophy, and endothelial dysfunction; Increased angiotensin II activity in diabetes worsens hypertension; Poor glycemic control accelerates diabetic complications including nephropathy and retinopathy
    • CBC/Blood and Bone Marrow: Evaluates hematopoiesis and immune function; Anemia reduces oxygen carrying capacity and increases cardiac workload; Anemia with hypertension increases stroke and MI risk; Elevated WBC suggests infection or inflammatory state; Abnormal counts may result from antihypertensive medications or secondary conditions
    • Urine Complete/Kidneys and Urinary Tract: Detects protein, glucose, and blood indicating kidney damage; Identifies UTI, stones, and other urinary abnormalities; Proteinuria indicates glomerulonephritis or hypertensive nephropathy; Hematuria requires investigation for malignancy or stones; Pyuria/bacteriuria indicates infection requiring treatment; Specific gravity assesses hydration status
    • Vitamin B12/Nervous System and Blood: Necessary for myelin formation and neurologic function; Deficiency causes polyneuropathy, myelopathy, and cognitive issues; B12 deficiency associated with elevated homocysteine (cardiovascular risk); Some antihypertensive medications impair absorption; Deficiency increases bleeding tendency
    • Vitamin D/Bones and Immune System: Regulates calcium and phosphate metabolism; Deficiency associated with osteoporosis and fracture risk; Low vitamin D linked to worse hypertension and increased cardiovascular events; Vitamin D modulates immune function and reduces inflammation; Supplementation may improve blood pressure control
  • Follow-up Tests
    • If Glucose Elevated: Oral glucose tolerance test (OGTT); Hemoglobin A1c if not already done; Consider diabetes referral; Repeat testing in 3-6 months if prediabetic; Monitor annually if normal; Lifestyle modification counseling
    • If Microalbumin Elevated: Repeat microalbumin test to confirm; 24-hour urine protein; Comprehensive metabolic panel; Kidney ultrasound to assess kidney size and echogenicity; Consider renal artery duplex if significant proteinuria; Refer to nephrology if progressive; ACE inhibitor/ARB therapy; Strict glycemic and blood pressure control
    • If Cortisol Elevated: 24-hour urinary free cortisol; Dexamethasone suppression test; Midnight salivary cortisol; ACTH level; High-resolution CT chest/abdomen if ACTH-producing tumor suspected; Pituitary MRI if Cushing disease suspected; Referral to endocrinology; Consider adrenal imaging
    • If Liver Function Tests Abnormal: Hepatitis serology (A, B, C); PT/INR to assess synthetic function; Liver ultrasound to assess structure and exclude cirrhosis; Consider fibroscan for fibrosis assessment; Refer to hepatology if significant dysfunction; Discontinue hepatotoxic medications; Alcohol cessation counseling; Repeat LFTs in 4-6 weeks to monitor trend
    • If Kidney Function Abnormal: Repeat creatinine and BUN in 2-4 weeks; Calculate KDIGO CKD-EPI eGFR; Cystatin C for alternative GFR estimation; 24-hour urine creatinine clearance; Urine electrolytes; Kidney ultrasound if eGFR <60 or acute change; Renal artery duplex if renovascular disease suspected; Refer to nephrology if CKD Stage 3 or higher; Monitor quarterly; Adjust medication dosing for renal function
    • If Lipid Profile Abnormal: Cardiovascular risk assessment (Framingham, ASCVD calculator); Consider statin therapy; Repeat lipid panel in 4-6 weeks after lifestyle intervention; Advanced lipid testing (apolipoprotein B, lipoprotein(a)); Coronary calcium score if intermediate risk; Cardiac stress testing if symptoms; Consider referral to cardiology; Intensive lifestyle modification; Repeat annually if managed
    • If Thyroid Profile Abnormal: Free T4 and Free T3 measurements; TPO antibodies; Thyroglobulin antibodies; Thyroid ultrasound if nodules suspected; Thyroid scan/uptake if hyperthyroidism; Consider endocrinology referral; Initiate thyroid replacement if hypothyroid; Beta-blockers for hyperthyroidism; Repeat TSH in 6-8 weeks after therapy initiation; Recheck annually
    • If HbA1c/Glucose Elevated: Fasting and postprandial glucose monitoring; Home glucose meter for self-monitoring; Diabetes education and lifestyle intervention; Consider metformin or other agents; Ophthalmology referral for diabetic retinopathy screening; Urine microalbumin for diabetic nephropathy; Monofilament testing for neuropathy; Foot examination; Repeat HbA1c every 3 months until stable, then annually
    • If CBC Abnormal: Peripheral blood smear; Iron studies if anemia; Reticulocyte count; Bone marrow biopsy if findings persistent; Hospitalization if severe anemia; Blood transfusion if Hb <7 g/dL; Blood cultures if fever present; Antibiotic therapy if infection; Repeat CBC in 1-2 weeks; Assess for medication-related effects
    • If Urine Complete Abnormal: Urine microscopy for casts, crystals, organisms; Urine culture if bacteria present; Urine electrolytes; 24-hour urine protein and creatinine; Renal ultrasound if hematuria; Cystoscopy if significant hematuria and >50 years old; CT urography for calcifications; Repeat UA after treatment; Hydration assessment; Prophylactic medications if recurrent stones
    • If Vitamin B12 Low: Methylmalonic acid and homocysteine levels; Intrinsic factor and parietal cell antibodies; Schilling test; Pernicious anemia assessment; Neurologic examination; Electromyography if neuropathy suspected; B12 intramuscular injections (monthly or quarterly); Oral high-dose B12 supplementation; Dietary counseling; Monitor neurologic status; Repeat B12 level after 3 months
    • If Vitamin D Deficient: PTH and serum calcium; Phosphate level; Alkaline phosphatase; Bone density study (DXA scan) if indicated; Vitamin D supplementation (50,000 IU weekly or daily formulations); Calcium supplementation if deficient; Dietary counseling for vitamin D sources; Sun exposure recommendations; Repeat vitamin D level in 8-12 weeks; Monitor blood pressure response; Long-term maintenance therapy
    • General Hypertension Follow-up: Home blood pressure monitoring; Electrocardiogram (ECG) to assess for left ventricular hypertrophy; Echocardiogram if ECG abnormalities; Carotid ultrasound for atherosclerosis assessment; Ophthalmologic examination for hypertensive retinopathy; Urinary sodium assessment; Plasma renin and aldosterone if secondary hypertension suspected; Renal artery imaging (ultrasound, CT, or MR angiography) if renovascular disease suspected; 24-hour ambulatory blood pressure monitoring; Office blood pressures at each visit; Annual monitoring of all baseline tests after stabilization
  • Fasting Required?
    • YES - Fasting required for this test package
    • Fasting Duration: 9-12 hours (typically overnight fasting; most labs require minimum 10 hours)
    • Fasting Guidelines: No food or calorie-containing drinks after midnight before morning test; Water consumption is permitted; Plain black coffee and tea without cream/sugar allowed (some labs); Schedule blood draw early morning (7-10 AM); Nothing by mouth except water from midnight
    • Medications to Continue: Continue all regular antihypertensive medications with small sip of water; Do NOT discontinue blood pressure medications before testing; Cardiac medications should be taken as prescribed; Diabetes medications: consult with provider (some may be held if fasting); Thyroid medication should be taken on morning of test with water only
    • Medications to Avoid/Discuss: Consult physician about holding metformin morning of test if eGFR low; Certain diabetes medications may need to be held; NSAIDs may affect kidney function results; Recent diuretics may affect electrolytes; Discuss with provider before holding any medications
    • Night Before Test: Normal dinner at regular time; Avoid excessive salt, fats, and alcohol; Adequate hydration throughout day; Light evening meal preferred; Avoid strenuous exercise; Get adequate sleep (6-8 hours); Eat at normal meal times up to midnight; Avoid sugary drinks and desserts
    • Day of Test: Arrive early (allow 15 minutes); Bring insurance card and ID; Sit for 5 minutes before blood draw for accurate BP; Arm should be at heart level; Avoid stress and anxiety; Do not exercise morning of test; Arrive well-hydrated; Inform technician of recent illnesses or medications
    • Special Urine Collection Instructions: Use first morning void for spot urine microalbumin test; Empty bladder completely for accurate results; Clean-catch midstream technique for urine culture (if needed); Can be collected anytime morning of test; Refrigerate if unable to deliver immediately
    • Cortisol-Specific Instructions: Morning cortisol (8-9 AM) most useful; May require 24-hour urine collection (follow separate instructions); Midnight salivary cortisol collection at home (follow lab instructions closely); Fasting not required for all cortisol tests; Timing critical for accurate interpretation
    • After Testing - Eating: May eat and drink immediately after blood draw; Light breakfast recommended after test; Drink fluids to rehydrate; Take diabetes medications after eating if held before test; Eat balanced meal within 1 hour; Continue normal daily routine
    • Lifestyle Considerations: Avoid strenuous exercise 24 hours before test; Travel should not occur day before; Recent infections may affect WBC results; Menstrual cycle may affect some parameters; Recent medication changes should be noted; Recent heart attack/stroke affects baseline status; Recent surgery affects immune markers; Fever/acute illness should be reported; Pregnancy status important for some tests

How our test process works!

customers
customers